Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

Michael A. Kutcher, M.D.

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentInt Med-Cardiovascular Med
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kutcher MA. Biodegradable-Polymer Drug-Eluting Stent Platforms: The Importance of Long-Term Outcomes. JACC Cardiovasc Interv. 2018 May 28; 11(10):1003-1005. PMID: 29798765.
      View in: PubMed
    2. Kutcher MA. Bioresorbable Vascular Scaffold Thrombosis: Solutions to the Problem? JACC Cardiovasc Interv. 2017 09 25; 10(18):1816-1818. PMID: 28935072.
      View in: PubMed
    3. Kutcher MA. The Bioresorbable Drug-Eluting Coronary Stent: The Price Is Right? JACC Cardiovasc Interv. 2017 04 24; 10(8):783-785. PMID: 28427594.
      View in: PubMed
    4. Vora AN, Peterson ED, McCoy LA, Garratt KN, Kutcher MA, Marso SP, Roe MT, Messenger JC, Rao SV. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv. 2016 Apr 25; 9(8):771-779. PMID: 27101904.
      View in: PubMed
    5. Kutcher MA. Door-to-Balloon Time as a Process Metric for Treatment of ST-Segment Elevation Myocardial Infarction: Time to "Tap Out"? JACC Cardiovasc Interv. 2015 Dec 28; 8(15):1975-1977. PMID: 26738668.
      View in: PubMed
    6. Jennings HS, Rao SV, Feldman DN, Kolansky DM, Kutcher MA, Baker NC, Chambers CE, Petit CJ, Cigarroa JE. SCAI core curriculum for adult and pediatric interventional fellowship training in continuous quality assessment and improvement. Catheter Cardiovasc Interv. 2015 Sep; 86(3):422-31. PMID: 25950289.
      View in: PubMed
    7. Hess CN, Peterson ED, Neely ML, Dai D, Hillegass WB, Krucoff MW, Kutcher MA, Messenger JC, Pancholy S, Piana RN, Rao SV. Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry". Circulation. 2015 Feb 24; 131(8):e358. PMID: 25712065.
      View in: PubMed
    8. Lazkani M, Eddin M, Lombardi WL, Kutcher M, Rizik D, Pershad A. Highlights of the Scottsdale Interventional Forum 2014, how-to symposiums: advances in chronic total occlusion therapy. J Invasive Cardiol. 2015 Feb; 27(2):E30-4. PMID: 25661769.
      View in: PubMed
    9. Hess CN, Peterson ED, Neely ML, Dai D, Hillegass WB, Krucoff MW, Kutcher MA, Messenger JC, Pancholy S, Piana RN, Rao SV. The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry. Circulation. 2014 Jun 03; 129(22):2277-86. PMID: 24756064.
      View in: PubMed
    10. Chin CT, Messenger JC, Dai D, McCoy LA, Kutcher MA, Anderson HV, Roe MT, Wang TY. Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry. Am Heart J. 2014 Mar; 167(3):393-400.e1. PMID: 24576525.
      View in: PubMed
    11. Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakyan A, Sedrakayan A, Booth ME, Douglas PS, Messenger JC. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. Catheter Cardiovasc Interv. 2014 Feb; 83(2):171-81. PMID: 23907981.
      View in: PubMed
    12. Kutcher MA. The "final voyage" of the Endeavor stent. JACC Cardiovasc Interv. 2013 May; 6(5):513-5. PMID: 23702014.
      View in: PubMed
    13. Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E375-84. PMID: 23074085.
      View in: PubMed
    14. Riley RF, Newby LK, Don CW, Alexander KP, Peterson ED, Peng SA, Gandhi SK, Kutcher MA, Amsterdam EA, Herrington DM. Guidelines-based treatment of anaemic STEMI patients: practice patterns and effects on in-hospital mortality: a retrospective analysis from the NCDR. Eur Heart J Acute Cardiovasc Care. 2013 Mar; 2(1):35-43. PMID: 24062932.
      View in: PubMed
    15. Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. Am J Cardiol. 2013 Feb 15; 111(4):486-92. PMID: 23211356.
      View in: PubMed
    16. Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington DM. Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Am Heart J. 2013 Jan; 165(1):50-6. PMID: 23237133.
      View in: PubMed
    17. Singh M, Holmes DR, Dehmer GJ, Lennon RJ, Wharton TP, Kutcher MA, Aversano T, Rihal CS. Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis. JAMA. 2011 Dec 14; 306(22):2487-94. PMID: 22166608.
      View in: PubMed
    18. Turner S, Sacrinty M, Manogue M, Little W, Gandhi S, Kutcher M, Santos R, Applegate R. Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):247-57. PMID: 22162430.
      View in: PubMed
    19. Chin CT, Weintraub WS, Dai D, Mehta RH, Rumsfeld JS, Anderson HV, Messenger JC, Kutcher MA, Peterson ED, Brindis RG, Rao SV. Trends and predictors of length of stay after primary percutaneous coronary intervention: a report from the CathPCI registry. Am Heart J. 2011 Dec; 162(6):1052-61. PMID: 22137079.
      View in: PubMed
    20. Kutcher MA. Second-generation everolimus-eluting stents and the beat goes on? JACC Cardiovasc Interv. 2011 Nov; 4(11):1216-7. PMID: 22115662.
      View in: PubMed
    21. Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):408-15. PMID: 21693724.
      View in: PubMed
    22. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010 Jun; 22(6):266-70. PMID: 20516505.
      View in: PubMed
    23. Kutcher MA. Cardiac magnetic resonance imaging to assess and predict improvement of myocardial function after percutaneous coronary intervention: a new standard? JACC Cardiovasc Interv. 2010 Apr; 3(4):401-2. PMID: 20398867.
      View in: PubMed
    24. Dehmer GJ, Kutcher MA. ST-segment-elevation myocardial infarction treated at hospitals with and without on-site cardiac surgery: do we have the answer and what about the future? Circ Cardiovasc Interv. 2009 Dec; 2(6):497-9. PMID: 20031765.
      View in: PubMed
    25. Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009 Jul 01; 74(1):64-73. PMID: 19202551.
      View in: PubMed
    26. Kutcher MA, Klein LW, Ou FS, Wharton TP, Dehmer GJ, Singh M, Anderson HV, Rumsfeld JS, Weintraub WS, Shaw RE, Sacrinty MT, Woodward A, Peterson ED, Brindis RG. Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol. 2009 Jun 30; 54(1):16-24. PMID: 19555835.
      View in: PubMed
    27. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J. 2009 Apr; 157(4):688-94. PMID: 19332197.
      View in: PubMed
    28. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2009 Mar; 2(3):231-9. PMID: 19463431.
      View in: PubMed
    29. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009 Feb; 2(1):35-42. PMID: 20031691.
      View in: PubMed
    30. Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL. Coronary artery stents: II. Perioperative considerations and management. Anesth Analg. 2008 Aug; 107(2):570-90. PMID: 18633036.
      View in: PubMed
    31. Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention. Anesth Analg. 2008 Aug; 107(2):552-69. PMID: 18633035.
      View in: PubMed
    32. Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA. Incidence of coronary stent thrombosis based on academic research consortium definitions. Am J Cardiol. 2008 Sep 15; 102(6):683-8. PMID: 18773988.
      View in: PubMed
    33. Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis. Catheter Cardiovasc Interv. 2008 Jul 01; 72(1):7-12. PMID: 18412239.
      View in: PubMed
    34. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv. 2008 Jun; 1(3):317-26. PMID: 19463320.
      View in: PubMed
    35. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting. Am Heart J. 2008 Aug; 156(2):234-40. PMID: 18657651.
      View in: PubMed
    36. Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC. Culprit vessel PCI versus traditional cath and PCI for STEMI. J Invasive Cardiol. 2008 May; 20(5):224-8. PMID: 18460706.
      View in: PubMed
    37. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res. 2008; 123(2):200-5. PMID: 18378281.
      View in: PubMed
    38. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008 Feb 12; 51(6):607-14. PMID: 18261678.
      View in: PubMed
    39. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Kahl FR, Santos RM, Little WC. Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005. J Invasive Cardiol. 2007 Sep; 19(9):369-74. PMID: 17827504.
      View in: PubMed
    40. Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, Krone RJ, Anderson HV, Kutcher MA, Marso SP. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol. 2007 Oct 01; 100(7):1114-8. PMID: 17884373.
      View in: PubMed
    41. McKee SA, Applegate RJ, Hoyle JR, Sacrinty MT, Kutcher MA, Sane DC. Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention. Am Heart J. 2007 Jul; 154(1):159-64. PMID: 17584570.
      View in: PubMed
    42. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual compression. J Invasive Cardiol. 2007 Apr; 19(4):164-70. PMID: 17404401.
      View in: PubMed
    43. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007 Feb 01; 99(3):333-8. PMID: 17261393.
      View in: PubMed
    44. Applegate RJ, Grabarczyk MA, Sane DC, Sacrinty MT, Goodin JE, Statonk GS, Baki TT, Gandhi SK, Kutcher MA, Little WC. PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. J Invasive Cardiol. 2006 Dec; 18(12):604-13. PMID: 17197712.
      View in: PubMed
    45. Dehmer GJ, Kutcher MA, Dey SK, Shaw RE, Weintraub WS, Mitchell K, Brindis RG. Frequency of percutaneous coronary interventions at facilities without on-site cardiac surgical backup--a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am J Cardiol. 2007 Feb 01; 99(3):329-32. PMID: 17261392.
      View in: PubMed
    46. Call J, Sacrinty M, Applegate R, Little W, Santos R, Baki T, Gandhi S, Kahl F, Kutcher M. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol. 2006 Oct; 18(10):469-74. PMID: 17042103.
      View in: PubMed
    47. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv. 2006 Apr; 67(4):556-62. PMID: 16532497.
      View in: PubMed
    48. Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC. Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol. 2006 Feb; 19(1):67-74. PMID: 16483343.
      View in: PubMed
    49. Anderson HV, Shaw RE, Brindis RG, Klein LW, McKay CR, Kutcher MA, Krone RJ, Wolk MJ, Smith SC, Weintraub WS. Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines. Circulation. 2005 Nov 01; 112(18):2786-91. PMID: 16267252.
      View in: PubMed
    50. Applegate RJ, Upadhya B, Little WC, Xenakis M, Gandhi SK, Baki TT, Kahl FR, Kutcher MA. Late outcomes after intervention of vein grafts in diabetics with abciximab use. Int J Cardiol. 2006 Jul 28; 111(1):136-41. PMID: 16226815.
      View in: PubMed
    51. Upadhya B, Applegate RJ, Sane DC, Deliargyris EN, Kutcher MA, Gandhi SK, Baki TT, Call JT, Little WC. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol. 2005 Aug 15; 96(4):515-8. PMID: 16098303.
      View in: PubMed
    52. Deliargyris EN, Upadhya B, Applegate RJ, Kontos JL, Kutcher MA, Riesmeyer JS, Sane DC. Safety of abciximab administration during PCI of patients with previous stroke. J Thromb Thrombolysis. 2005 Jun; 19(3):147-53. PMID: 16082601.
      View in: PubMed
    53. Upadhya B, Sane DC, Applegate RJ, Kutcher MA, Gandhi SK, Deliargyris EN. Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention. J Invasive Cardiol. 2005 May; 17(5):243-7. PMID: 15879602.
      View in: PubMed
    54. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005 Apr 19; 45(8):1172-9. PMID: 15837245.
      View in: PubMed
    55. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Kutcher M, Wong SC, Strickland W, Mooney M, Russell ME, Ellis SG, Stone GW. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005 Apr 19; 45(8):1201-5. PMID: 15837249.
      View in: PubMed
    56. Deliargyris EN, Upadhya B, Applegate RJ, Kutcher MA, Gandhi SK, Sane DC. Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous coronary interventions. J Invasive Cardiol. 2004 Nov; 16(11):611-6. PMID: 15550727.
      View in: PubMed
    57. Applegate RJ, Rankin KM, Little WC, Kahl FR, Kutcher MA. Restick following initial Angioseal use. Catheter Cardiovasc Interv. 2003 Feb; 58(2):181-4. PMID: 12552540.
      View in: PubMed
    58. Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR, Braden GA, Rankin KM, Kutcher MA. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002 Jul 03; 40(1):78-83. PMID: 12103259.
      View in: PubMed
    Kutcher's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _